Name: CLBT Income Statement - Cellebrite Di Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

CLBT - Cellebrite Di Ltd.

USD | NASDAQ | Technology

CLBT Income Statement - Cellebrite Di Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenues
Revenues	475.7	401.2	325.1	270.7	246.2	194.9	171.9
Cost of Revenue	75.2	62.6	53.2	50.7	42.6	37.9	35.8
Gross Profit	400.5	338.6	271.9	219.9	203.7	157.0	136.0
Operating Expenses
Research & Development	113.9	98.4	84.4	80.6	65.5	54.4	46.6
Selling General & Administrative	-	-	-	-	-	-
Operating Income
Operating Income	66.5	56.9	33.2	1.0	13.8	9.2	(1.5)
Non-Operating
Interest Income	22.9	18.2	10.6	2.0	0.8	2.7	3.5
Interest Expense	-	-	-	-	-	-	-
Tax & Net
Income Tax Expense	12.4	7.0	5.5	(0.0)	10.9	5.6	3.3
Net Income From Continuing Ops	78.3	(283.0)	(81.1)	120.8	71.4	5.8
Per Share
EPS Basic	0.32	(1.35)	(0.43)	0.64	0.49	(0.08)	(0.08)
EPS Diluted	0.31	(1.35)	(0.43)	0.59	0.44	(0.08)	(0.08)
Supplementary Data
EBITDA	78.3	67.5	43.2	10.2	20.8	15.1	2.6
EBIT	66.5	56.9	33.2	1.0	13.8	9.2	(1.5)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)